ABBV Buybacks
27 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–27; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| AbbVie Inc. | 2026-03-31 | Reported repurchase cash | $1.49B |
| AbbVie Inc. | 2025-12-31 | Reported repurchase cash | $3M |
| AbbVie Inc. | 2025-03-31 | Reported repurchase cash | $961M |
| AbbVie Inc. | 2024-12-31 | Reported repurchase cash | $358M |
| AbbVie Inc. | 2024-03-31 | Reported repurchase cash | $1.32B |
| AbbVie Inc. | 2023-12-31 | Reported repurchase cash | $3M |
| AbbVie Inc. | 2023-03-31 | Reported repurchase cash | $1.96B |
| AbbVie Inc. | 2022-12-31 | Reported repurchase cash | $4M |
| AbbVie Inc. | 2022-03-31 | Reported repurchase cash | $1.47B |
| AbbVie Inc. | 2021-12-31 | Reported repurchase cash | $131M |
| AbbVie Inc. | 2021-03-31 | Reported repurchase cash | $787M |
| AbbVie Inc. | 2020-12-31 | Reported repurchase cash | $296M |
| AbbVie Inc. | 2020-03-31 | Reported repurchase cash | $643M |
| AbbVie Inc. | 2019-12-31 | Reported repurchase cash | $2M |
| AbbVie Inc. | 2019-03-31 | Reported repurchase cash | $620M |
| AbbVie Inc. | 2018-12-31 | Reported repurchase cash | $2.06B |
| AbbVie Inc. | 2018-03-31 | Reported repurchase cash | $1.43B |
| AbbVie Inc. | 2017-12-31 | Reported repurchase cash | $505M |
| AbbVie Inc. | 2017-03-31 | Reported repurchase cash | $895M |
| AbbVie Inc. | 2016-12-31 | Reported repurchase cash | $1.81B |
| AbbVie Inc. | 2016-03-31 | Reported repurchase cash | $409M |
| AbbVie Inc. | 2015-12-31 | Reported repurchase cash | $1.24B |
| AbbVie Inc. | 2015-03-31 | Reported repurchase cash | $342M |
| AbbVie Inc. | 2014-12-31 | Reported repurchase cash | $313M |
| AbbVie Inc. | 2014-03-31 | Reported repurchase cash | $329M |
| AbbVie Inc. | 2013-12-31 | Reported repurchase cash | $201M |
| AbbVie Inc. | 2013-03-31 | Reported repurchase cash | $97M |